Bob DeMarco Alzheimer's Reading Room

Wednesday, June 11, 2008

Banner Alzheimer’s Institute and Sun Health Research Institute Enrolling Patients in Alzheimer's Study


If you or a loved one are taking Aricept you should find this announcement of interest. Follow the link to Banner Health for additional information.
Banner Alzheimer’s Institute and Sun Health Research Institute today announced that they are actively enrolling patients in a new study of the investigational drug Dimebon™ for the treatment of Alzheimer’s disease. The study will evaluate the safety and efficacy of Dimebon in patients with Alzheimer’s disease taken in combination with Aricept® (donepezil HCI tablets), an FDA-approved Alzheimer’s treatment.

Results from a one-year study of Dimebon in mild-to-moderate Alzheimer’s disease – showing statistically significant improvements in memory, thinking, function and behavior – were highlighted at the recent 2008 Arizona Alzheimer’s Consortium (AAC) Annual Conference, a community service event. Banner Alzheimer’s Institute and Sun Health Research Institute are both members of the Consortium.

blog it

Subscribe to The Alzheimer's Reading Room--via Email


Popular articles on the Alzheimer's Reading Room

The Alzheimer's Action Plan: The Experts' Guide to the Best Diagnosis and Treatment for Memory Problemsstyle

Bob DeMarco is the editor of the Alzheimer's Reading Room and an Alzheimer's caregiver. The Alzheimer's Reading Room is the number one website on the Internet for news, advice, and insight into Alzheimer's disease. Bob has written more than 800 articles with more than 18,000 links on the Internet. Bob resides in Delray Beach, FL.

Original content Bob DeMarco, Alzheimer's Reading Room